根据提供的文献内容，我将按照要求提取并结构化相关信息。以下是提取和标准化后的信息：

```json
{
    "Variants Include": [
        {
            "Gene": "LRRK2",
            "variants": [
                {
                    "HGVS": "NM_198578.2:c.7153G>C",
                    "cDNA Change": {
                        "transcript": "NM_198578.2",
                        "ref": "G",
                        "alt": "C",
                        "position": "7153"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "R",
                        "position": "2385"
                    },
                    "Description in input context": "c.7153G>C (p.G2385R)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005359"
    },
    "Experiment Method": [
        {
            "Assay Method": "Cell Transfection and Apoptosis Detection",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "HEK-293T",
                "Description": "Human embryonic kidney cells (HEK-293T) were maintained and transfected with plasmid DNA encoding wild-type or Gly2385Arg mutant LRRK2 protein."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_198578.2:c.7153G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "Pro-apoptotic",
                    "Result Description": "Overexpression of the Gly2385Arg variant in HEK-293T cells resulted in a higher rate of apoptosis and cell death under oxidative stress conditions (0.8 mM H2O2)."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were performed in multiple sets of biological replicates."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type LRRK2 protein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Chi-square test, Student t-test, Logistic regression analysis"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释与说明：
1. **Variants Include**：提取了文献中提到的LRRK2基因中的Gly2385Arg变异，并标准化为HGVS命名法（NM_198578.2:c.7153G>C）。
2. **Described Disease**：确定文献研究的疾病是帕金森病（Parkinson's disease），并从MONDO数据库检索到对应的术语（MONDO:0005359）。
3. **Experiment Method**：详细描述了实验方法，包括细胞转染和凋亡检测。提供了材料来源、读出类型、结果描述、生物学和技术重复、对照设置、统计分析方法等信息。
4. **Readout description**：对于每个实验方法，列出了所有变异的结果描述，包括结论和分子效应。

### 注意事项：
- 对于未在文献中明确提及的内容（如验证对照和正常/异常结果阈值），使用"N.D."表示。
- 确保提取的信息准确且符合科学文献标准。